查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662692

2030 年糖尿病溃疡治疗市场预测：按类型、治疗类型、最终用户和地区进行的全球分析

Diabetic Ulcer Treatment Market Forecasts to 2030 - Global Analysis by Type (Foot Ulcers, Leg Ulcers, Mouth Ulcer, Skin Ulcer and Other Types), Treatment Type (Wound Care Dressings, Biologics and Wound Care Devices), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球糖尿病溃疡治疗市场价值为 45 亿美元，预计到 2030 年将达到 83 亿美元，预测期内的复合年增长率为 10.5%。

糖尿病溃疡治疗是指采用医疗措施修復糖尿病患者皮肤上（通常发生在足部和小腿）出现的溃疡或溃疡。高血糖、神经损伤和血液循环不良都会影响身体癒合伤口的能力，导致溃疡。治疗包括控制血糖值、伤口护理、预防感染和保持脚部清洁。先进的治疗方法可能包括清创、减压装置、敷料，在极端情况下还包括手术。

根据 JAMA Network 报导，罹患糖尿病足溃疡 (DFU) 的一生风险为 19-34%。

糖尿病盛行率不断上升

糖尿病盛行率的上升是糖尿病溃疡治疗市场发展的主要驱动力。随着血液循环不良和神经损伤等糖尿病相关併发症的增加，糖尿病足溃疡的发生率不断上升，对有效治疗的需求也越来越大。病例激增推动了对先进创伤护理解决方案的需求，包括敷料、清创和感染控制。此外，治疗方法的创新和对早期疗育重要性的认识不断提高也促进了市场的扩大。

医疗费用高昂

治疗费用高是阻碍糖尿病溃疡治疗市场成长的主要因素。患者，尤其是低收入社区的患者，难以获得先进的治疗，从而限制了他们获得有效护理的机会。经济负担常会导致治疗延误，进而造成患者治疗效果较差。此外，医疗保健系统在长期照护资金方面面临挑战，影响了高成本糖尿病溃疡治疗的市场需求。这些经济障碍阻碍了创新治疗方法的采用。

治疗方案的进展

治疗方案的进步正在极大地推动糖尿病溃疡治疗市场的发展。先进的伤口敷料、生长因子疗法、干细胞疗法和再生医学等创新技术正在改善癒合并减少併发症。此外，伤口护理（NPWT）和生物工程皮肤替代等技术正在提高恢復率。这些突破性技术正在提高治疗效果、改善患者治疗效果并扩大市场。因此，对先进治疗的需求正在推动市场成长。

医疗服务有限

医疗保健机会有限限制了患者及时接受诊断、护理和治疗的能力，严重阻碍了糖尿病溃疡治疗市场的成长。这个问题在农村和低收入地区尤其普遍，因为这些地区获得专科医疗中心和合格医疗专业人员的机会有限。因此，延迟或不充分的治疗会增加併发症的风险，导致截肢率上升和对先进治疗的需求减少，最终减缓市场成长潜力。

COVID-19 的影响

COVID-19 疫情对糖尿病溃疡治疗市场产生了重大影响，导致医疗服务中断、患者就诊量减少以及选择性手术延迟。医院新冠肺炎病例不堪重负，人们的注意力不再集中在糖尿病溃疡等非紧急情况。结果，市场成长放缓。然而，疫情加速了远端医疗和居家照护解决方案的采用，为糖尿病溃疡的远端系统管理和治疗提供了新的机会。

预计口腔炎细分市场在预测期内将占最大份额

糖尿病患者发生口腔溃疡的风险通常是由于血糖控制不佳造成的，因此预计口腔溃疡领域将在预测期内占据最大的市场占有率。这些溃疡需要专门的治疗，因为它们可能导致感染疾病等併发症并影响您的整体健康。人们对糖尿病治疗中足部和口腔溃疡管理的认识不断提高，以及创伤治疗和感染管理的进步，推动了对综合治疗方案的需求，从而推动了市场成长。

预计预测期内居家医疗领域将实现最高的复合年增长率。

预计预测期内居家医疗领域将呈现最高的成长率。这是因为对于专业和客製化治疗的需求不断增加，居家医疗提供者现在提供创伤护理、感染控制和足部护理建议，以便更快地康復。此外，远端医疗和远端监控的改进使医疗专业人员能够监控患者的进展并优化治疗方法。由于居家照护的转变减少了住院时间和费用，糖尿病溃疡治疗市场正在扩大。

比最大的地区

在预测期内，由于糖尿病盛行率上升、人口老化以及人们对糖尿病足部护理认识的提高，预计北美将占据最大的市场占有率。先进敷料和生技药品等伤口护理技术的进步以及医疗保健基础设施的改善促进了市场的成长。此外，政府措施、增加医疗支出和预防保健的转变也是主要驱动因素。对创新治疗和改善患者结果的需求进一步推动了市场扩张。

复合年增长率最高的地区

预计预测期内亚太地区将呈现最高的复合年增长率。这是由于糖尿病盛行率不断上升、人们对糖尿病足部併发症认识的提高以及伤口护理技术的进步。人口老化和医疗保健机会的改善推动了对有效治疗的需求。此外，生技药品、先进敷料和创伤护理产品的创新也促进了市场的成长。政府倡议以及医疗保健基础设施的改善也支持了该地区糖尿病溃疡治疗方案的扩大。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球糖尿病溃疡治疗市场按类型

  • 介绍
  • 足部溃疡
    • 神经缺血性溃疡
    • 神经性溃疡
    • 缺血性溃疡
  • 腿部溃疡
  • 口腔炎
  • 皮肤溃疡
  • 其他的

6. 全球糖尿病溃疡治疗市场依治疗类型划分

  • 介绍
  • 创伤护理敷料
    • 抗菌敷料
    • 海藻酸盐敷料
    • 水凝胶敷料
    • 泡棉敷料
    • 膜敷料
    • 亲水胶体敷料
    • 其他创伤护理敷料
  • 生技药品
    • 皮肤移植和皮肤替代
    • 生长因子
  • 创伤护理设备
    • 负压伤口治疗法
    • 高压氧气疗法
    • 压力释放装置
    • 电磁疗法
    • 超音波治疗

7. 全球糖尿病溃疡治疗市场（依最终用户划分）

  • 介绍
  • 医院
  • 门诊手术中心
  • 居家医疗
  • 其他的

8. 全球糖尿病溃疡治疗市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第九章 主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司概况

  • 3M Health Care
  • Acelity LP, Inc.
  • AOTI
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health
  • Coloplast Corp.
  • ConvaTec Group Plc
  • Emblation
  • Integra LifeSciences
  • IPCA Laboratories
  • Medline Industries, LP
  • Medtronic Plc
  • MIMEDX
  • Molnlycke Health Care AB
  • Novalead Pharma
  • Organogenesis Inc.
  • Smith & Nephew Plc
  • Tissue Regenix
Product Code: SMRC28553

According to Stratistics MRC, the Global Diabetic Ulcer Treatment Market is accounted for $4.5 billion in 2024 and is expected to reach $8.3 billion by 2030 growing at a CAGR of 10.5% during the forecast period. Diabetic ulcer therapy refers to medical measures used to repair ulcers or sores that occur on the skin of diabetics, usually on the feet or lower limbs. High blood sugar, nerve damage, and poor circulation all hinder the body's capacity to heal wounds, which leads to these ulcers. Blood sugar control, wound care, infection prevention, and maintaining good foot cleanliness are all part of the treatment. Advanced treatments include debridement, pressure relief equipment, dressings, and, in extreme situations, surgery, may be necessary in some situations.

According to the JAMA Network, the lifetime risk of developing a diabetic foot ulcer (DFU) is between 19% and 34%.

Market Dynamics:

Driver:

Rising Prevalence of Diabetes

The rising prevalence of diabetes is significantly driving the diabetic ulcer treatment market. As diabetes-related complications, including poor circulation and nerve damage, increase, the incidence of diabetic foot ulcers grows, creating a higher demand for effective treatments. This surge in cases fuels the need for advanced wound care solutions, including dressings, debridement, and infection management. Additionally, innovations in therapies and increased awareness about the importance of early intervention further contribute to the expansion of this market.

Restraint:

High Treatment Costs

High treatment costs are a significant hindrance to the growth of the diabetic ulcer treatment market. Patients, particularly in low-income regions, struggle with the affordability of advanced therapies, which limits access to effective care. The financial burden often leads to delays in treatment, worsening patient outcomes. Additionally, healthcare systems face challenges in covering expenses for long-term care, affecting market demand for high-cost diabetic ulcer treatments. This financial barrier slows the adoption of innovative treatment options.

Opportunity:

Advancements in Treatment Options

Advancements in treatment options are significantly driving the diabetic ulcer treatment market. Innovations like advanced wound dressings, growth factor therapies, stem cell treatments, and regenerative medicine offer improved healing and reduce complications. Additionally, technologies like negative pressure wound therapy (NPWT) and bioengineered skin substitutes enhance recovery rates. These breakthroughs are increasing the efficacy of treatments, leading to better patient outcomes and expanding the market. As a result, demand for advanced treatments, propelling market growth.

Threat:

Limited Healthcare Access

Limited healthcare access significantly hinders the growth of the diabetic ulcer treatment market by restricting patients' ability to receive timely diagnosis, care, and treatment. This issue is particularly prevalent in rural or low-income regions, where access to specialized medical centers and qualified healthcare professionals is limited. As a result, delayed or inadequate treatment increases the risk of complications, leading to higher amputation rates and reduced demand for advanced therapies, ultimately slowing the market's potential growth.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the diabetic ulcer treatment market, leading to disruptions in healthcare services, reduced patient visits, and delays in elective procedures. Hospitals were overwhelmed with COVID cases, shifting focus away from non-urgent conditions like diabetic ulcers. This resulted in a decline in market growth. However, the pandemic also accelerated the adoption of telemedicine and home-based care solutions, offering new opportunities for remote diabetic ulcer management and treatment.

The mouth ulcer segment is expected to be the largest during the forecast period

The mouth ulcer segment is expected to account for the largest market share during the forecast period, due to increased risk of oral ulcers in diabetic patients, often caused by poor blood sugar control. These ulcers can lead to complications like infections and affect overall health, prompting the need for specialized treatments. The growing awareness of managing both foot and oral ulcers in diabetic care, along with advances in wound healing and infection control, boosts demand for comprehensive treatment options, thus driving market growth.

The homecare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecare segment is predicted to witness the highest growth rate because of the growing knowledge and need for tailored treatment, homecare providers now include wound care, infection management, and foot care advice, allowing for speedier recovery. Furthermore, improvements in telemedicine and remote monitoring enable medical practitioners to monitor patients' progress and optimize treatment regimens. The market for diabetic ulcer therapy is expanding as a result of the move towards homecare, which lowers hospital stays and expenses.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to rising prevalence of diabetes, an aging population, and increasing awareness about diabetic foot care. Advancements in wound care technologies, such as advanced dressings and biologics, along with improved healthcare infrastructure, contribute to market growth. Additionally, government initiatives, growing healthcare spending, and a shift toward preventive care are key drivers. The need for innovative treatments and better patient outcomes further fuels market expansion.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR because rising prevalence of diabetes, increasing awareness of diabetic foot complications, and advancements in wound care technology. The growing aging population, coupled with higher healthcare access, boosts demand for effective treatments. Moreover, innovations in biologics, advanced dressings, and wound care products further contribute to market growth. Government initiatives, along with improved healthcare infrastructure, also support the expansion of diabetic ulcer treatment solutions in the region.

Key players in the market

Some of the key players in Diabetic Ulcer Treatment market include 3M Health Care, Acelity L.P., Inc., AOTI, B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Coloplast Corp., ConvaTec Group Plc, Emblation, Integra LifeSciences, IPCA Laboratories, Medline Industries, LP, Medtronic Plc, MIMEDX, Molnlycke Health Care AB, Novalead Pharma, Organogenesis Inc, Smith & Nephew Plc and Tissue Regenix.

Key Developments:

In October 2024, Royal Philips and Medtronic Neurovascular announced a strategic advocacy partnership. Delivering timely stroke care is crucial to saving lives and reducing long-term disability.

In September 2024, Medtronic plc announced the commercial launch of several software, hardware, and imaging innovations. These enhancements are designed to advance AiBLE, the Medtronic smart ecosystem of innovative navigation, robotics, data and AI, imaging, software and implants that enable more predictable outcomes in spine and cranial procedures.

In January 2024, Medtronic plc announced a strategic collaboration with Cardiac Design Labs (CDL) to launch, scale up, and expand access to CDL's novel diagnostic technology, Padma Rhythms, an external loop recorder (ELR) patch designed for comprehensive, long-term heart monitoring and diagnosis.

Types Covered:

  • Foot Ulcers
  • Leg Ulcers
  • Mouth Ulcer
  • Skin Ulcer
  • Other Types

Treatment Types Covered:

  • Wound Care Dressings
  • Biologics
  • Wound Care Devices

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Diabetic Ulcer Treatment Market, By Type

  • 5.1 Introduction
  • 5.2 Foot Ulcers
    • 5.2.1 Neuro-ischemic Ulcer
    • 5.2.2 Neuropathic Ulcer
    • 5.2.3 Ischemic Ulcer
  • 5.3 Leg Ulcers
  • 5.4 Mouth Ulcer
  • 5.5 Skin Ulcer
  • 5.6 Other Types

6 Global Diabetic Ulcer Treatment Market, By Treatment Type

  • 6.1 Introduction
  • 6.2 Wound Care Dressings
    • 6.2.1 Antimicrobial Dressing
    • 6.2.2 Alginate Dressing
    • 6.2.3 Hydrogel Dressing
    • 6.2.4 Foam Dressing
    • 6.2.5 Film Dressing
    • 6.2.6 Hydrocolloid Dressing
    • 6.2.7 Others Wound Care Dressings
  • 6.3 Biologics
    • 6.3.1 Skin Grafts and Substitutes
    • 6.3.2 Growth Factors
  • 6.4 Wound Care Devices
    • 6.4.1 Negative Pressure Wound Therapy
    • 6.4.2 Hyperbaric Oxygen Therapy
    • 6.4.3 Pressure Relief Devices
    • 6.4.4 Electromagnetic Therapy
    • 6.4.5 Ultrasound Therapy

7 Global Diabetic Ulcer Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Homecare
  • 7.5 Other End Users

8 Global Diabetic Ulcer Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Health Care
  • 10.2 Acelity L.P., Inc.
  • 10.3 AOTI
  • 10.4 B. Braun Melsungen AG
  • 10.5 BSN Medical GmbH
  • 10.6 Cardinal Health
  • 10.7 Coloplast Corp.
  • 10.8 ConvaTec Group Plc
  • 10.9 Emblation
  • 10.10 Integra LifeSciences
  • 10.11 IPCA Laboratories
  • 10.12 Medline Industries, LP
  • 10.13 Medtronic Plc
  • 10.14 MIMEDX
  • 10.15 Molnlycke Health Care AB
  • 10.16 Novalead Pharma
  • 10.17 Organogenesis Inc.
  • 10.18 Smith & Nephew Plc
  • 10.19 Tissue Regenix

List of Tables

  • Table 1 Global Diabetic Ulcer Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Diabetic Ulcer Treatment Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Diabetic Ulcer Treatment Market Outlook, By Foot Ulcers (2022-2030) ($MN)
  • Table 4 Global Diabetic Ulcer Treatment Market Outlook, By Neuro-ischemic Ulcer (2022-2030) ($MN)
  • Table 5 Global Diabetic Ulcer Treatment Market Outlook, By Neuropathic Ulcer (2022-2030) ($MN)
  • Table 6 Global Diabetic Ulcer Treatment Market Outlook, By Ischemic Ulcer (2022-2030) ($MN)
  • Table 7 Global Diabetic Ulcer Treatment Market Outlook, By Leg Ulcers (2022-2030) ($MN)
  • Table 8 Global Diabetic Ulcer Treatment Market Outlook, By Mouth Ulcer (2022-2030) ($MN)
  • Table 9 Global Diabetic Ulcer Treatment Market Outlook, By Skin Ulcer (2022-2030) ($MN)
  • Table 10 Global Diabetic Ulcer Treatment Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 11 Global Diabetic Ulcer Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 12 Global Diabetic Ulcer Treatment Market Outlook, By Wound Care Dressings (2022-2030) ($MN)
  • Table 13 Global Diabetic Ulcer Treatment Market Outlook, By Antimicrobial Dressing (2022-2030) ($MN)
  • Table 14 Global Diabetic Ulcer Treatment Market Outlook, By Alginate Dressing (2022-2030) ($MN)
  • Table 15 Global Diabetic Ulcer Treatment Market Outlook, By Hydrogel Dressing (2022-2030) ($MN)
  • Table 16 Global Diabetic Ulcer Treatment Market Outlook, By Foam Dressing (2022-2030) ($MN)
  • Table 17 Global Diabetic Ulcer Treatment Market Outlook, By Film Dressing (2022-2030) ($MN)
  • Table 18 Global Diabetic Ulcer Treatment Market Outlook, By Hydrocolloid Dressing (2022-2030) ($MN)
  • Table 19 Global Diabetic Ulcer Treatment Market Outlook, By Others Wound Care Dressings (2022-2030) ($MN)
  • Table 20 Global Diabetic Ulcer Treatment Market Outlook, By Biologics (2022-2030) ($MN)
  • Table 21 Global Diabetic Ulcer Treatment Market Outlook, By Skin Grafts and Substitutes (2022-2030) ($MN)
  • Table 22 Global Diabetic Ulcer Treatment Market Outlook, By Growth Factors (2022-2030) ($MN)
  • Table 23 Global Diabetic Ulcer Treatment Market Outlook, By Wound Care Devices (2022-2030) ($MN)
  • Table 24 Global Diabetic Ulcer Treatment Market Outlook, By Negative Pressure Wound Therapy (2022-2030) ($MN)
  • Table 25 Global Diabetic Ulcer Treatment Market Outlook, By Hyperbaric Oxygen Therapy (2022-2030) ($MN)
  • Table 26 Global Diabetic Ulcer Treatment Market Outlook, By Pressure Relief Devices (2022-2030) ($MN)
  • Table 27 Global Diabetic Ulcer Treatment Market Outlook, By Electromagnetic Therapy (2022-2030) ($MN)
  • Table 28 Global Diabetic Ulcer Treatment Market Outlook, By Ultrasound Therapy (2022-2030) ($MN)
  • Table 29 Global Diabetic Ulcer Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 Global Diabetic Ulcer Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 31 Global Diabetic Ulcer Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 32 Global Diabetic Ulcer Treatment Market Outlook, By Homecare (2022-2030) ($MN)
  • Table 33 Global Diabetic Ulcer Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.